Literature DB >> 27505329

Geographic and socio-demographic differences in uptake of population-based screening for atrial fibrillation: The STROKESTOP I study.

Johan Engdahl1, Anders Holmén2, Emma Svennberg3, Leif Friberg3, Viveka Frykman-Kull3, Faris Al-Khalili4, Mårten Rosenqvist3, Ulf Strömberg5.   

Abstract

BACKGROUND: The rationale behind screening for atrial fibrillation (AF) is to prevent ischemic stroke. Socio-demographic differences are expected to affect screening uptake. Geographic differences may provide further insights leading to targeted interventions for improved uptake. The objective of this study was to evaluate geographic and socio-demographic differences in uptake of AF screening in the population-based study STROKESTOP I.
METHODS: STROKESTOP was carried out in two Swedish counties with a total population of 2.3 million inhabitants. Half of the residents aged 75-76years were randomized to the screening arm: invitation to clinical examination followed by ambulant ECG recording. Information on each invited person's residential parish (n=157) was used. On parish-level, aggregated data for the participants and non-participants, respectively, were obtained with respect to socioeconomic variables: educational level, disposable income, immigrant and marital status. Geo-maps displaying participation ratios were estimated by hierarchical Bayes methods.
RESULTS: The overall participation rate was similar in men and women but lower in Stockholm, 47.6% (5665/11,903) than in Halland, 61.2% (1495/2443). Participation was clearly associated with the socioeconomic variables. Participation not taking into account socioeconomy varied more markedly across the parishes in the Stockholm county (range: 0.65-1.26) than in the Halland county (0.94-1.27). After adjustment for socioeconomic variables, a geographic variation remained in Stockholm, but not in Halland.
CONCLUSION: Participation in AF screening varied according to socioeconomic conditions. Geographic variation in participation was marked in the Stockholm county, with only one screening clinic. Geo-mapping of participation yielded useful information needed to intervene for improved screening uptake.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Participation; Screening; Socioeconomy; Stroke prevention

Mesh:

Year:  2016        PMID: 27505329     DOI: 10.1016/j.ijcard.2016.07.198

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

Review 1.  Large-scale screening studies for atrial fibrillation - is it worth the effort?

Authors:  J Engdahl; M Rosenqvist
Journal:  J Intern Med       Date:  2021-01-07       Impact factor: 8.989

2.  Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study.

Authors:  Katrin Kemp Gudmundsdottir; Tove Fredriksson; Emma Svennberg; Faris Al-Khalili; Leif Friberg; Viveka Frykman; Ziad Hijazi; Mårten Rosenqvist; Johan Engdahl
Journal:  Europace       Date:  2020-01-01       Impact factor: 5.214

3.  Decentralising atrial fibrillation screening to overcome socio-demographic inequalities in uptake in STROKESTOP II.

Authors:  Katrin Kemp Gudmundsdottir; Anders Holmen; Tove Fredriksson; Emma Svennberg; Faris Al-Khalili; Johan Engdahl; Ulf Strömberg
Journal:  J Med Screen       Date:  2020-03-30       Impact factor: 2.136

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.